Skip Nav Destination
Issues
1 June 2016
-
Cover Image
Cover Image
Spiegel and colleagues investigated the function of neutrophils in the intermediate stages of the invasion–metastasis cascade. Splenectomy to reduce the reservoir of myeloid cells suppressed pulmonary metastases in a murine mammary carcinoma model, and was associated with neutrophilia. Further, G-CSF overexpression phenocopied the neutrophilia and metastatic potential of the cancer cells, and G-CSF–induced neutrophils enhanced metastasis after intravasation but before postextravasation colonization. Neutrophils protected cancer cells from natural killer (NK) cell–mediated clearance while still within the lumina of the microvessels. Overall, these results indicate that neutrophils can suppress the activity of NK cells and promote tumor cell extravasation. For details, please see the article by Spiegel and colleagues on page 630. Cover image courtesy of Asaf Spiegel. - PDF Icon PDF LinkTable of Contents
ISSN 2159-8274
EISSN 2159-8290
Issue Sections
In This Issue
In the Spotlight
Review
Research Briefs
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy
Samuel J. Klempner; Bruce Gershenhorn; Phu Tran; Thomas K. Lee; Mark G. Erlander; Kyle Gowen; Alexa B. Schrock; Deborah Morosini; Jeffrey S. Ross; Vincent A. Miller; Philip J. Stephens; Sai-Hong Ignatius Ou; Siraj M. Ali
Author Choice
EGFR Fusions as Novel Therapeutic Targets in Lung Cancer
Kartik Konduri; Jean-Nicolas Gallant; Young Kwang Chae; Francis J. Giles; Barbara J. Gitlitz; Kyle Gowen; Eiki Ichihara; Taofeek K. Owonikoko; Vijay Peddareddigari; Suresh S. Ramalingam; Satyanarayan K. Reddy; Beth Eaby-Sandy; Tiziana Vavalà; Andrew Whiteley; Heidi Chen; Yingjun Yan; Jonathan H. Sheehan; Jens Meiler; Deborah Morosini; Jeffrey S. Ross; Philip J. Stephens; Vincent A. Miller; Siraj M. Ali; Christine M. Lovly
Research Articles
Author Choice
BRD4 Connects Enhancer Remodeling to Senescence Immune Surveillance
Nilgun Tasdemir; Ana Banito; Jae-Seok Roe; Direna Alonso-Curbelo; Matthew Camiolo; Darjus F. Tschaharganeh; Chun-Hao Huang; Ozlem Aksoy; Jessica E. Bolden; Chi-Chao Chen; Myles Fennell; Vishal Thapar; Agustin Chicas; Christopher R. Vakoc; Scott W. Lowe
Neutrophils Suppress Intraluminal NK Cell–Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
Asaf Spiegel; Mary W. Brooks; Samin Houshyar; Ferenc Reinhardt; Michele Ardolino; Evelyn Fessler; Michelle B. Chen; Jordan A. Krall; Jasmine DeCock; Ioannis K. Zervantonakis; Alexandre Iannello; Yoshiko Iwamoto; Virna Cortez-Retamozo; Roger D. Kamm; Mikael J. Pittet; David H. Raulet; Robert A. Weinberg
Author Choice
In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
Daniela Bossi; Angelo Cicalese; Gaetano I. Dellino; Lucilla Luzi; Laura Riva; Carolina D'Alesio; Giuseppe R. Diaferia; Alessandro Carugo; Elena Cavallaro; Rossana Piccioni; Massimo Barberis; Giovanni Mazzarol; Alessandro Testori; Simona Punzi; Isabella Pallavicini; Giulio Tosti; Luciano Giacó; Giorgio Melloni; Timothy P. Heffernan; Gioacchino Natoli; Giulio F. Draetta; Saverio Minucci; PierGiuseppe Pelicci; Luisa Lanfrancone
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
David T. Teachey; Simon F. Lacey; Pamela A. Shaw; J. Joseph Melenhorst; Shannon L. Maude; Noelle Frey; Edward Pequignot; Vanessa E. Gonzalez; Fang Chen; Jeffrey Finklestein; David M. Barrett; Scott L. Weiss; Julie C. Fitzgerald; Robert A. Berg; Richard Aplenc; Colleen Callahan; Susan R. Rheingold; Zhaohui Zheng; Stefan Rose-John; Jason C. White; Farzana Nazimuddin; Gerald Wertheim; Bruce L. Levine; Carl H. June; David L. Porter; Stephan A. Grupp
News in Brief
Research Watch
Breast Cancer
Chemotherapy
Clinical Trials
Colorectal Cancer
Leukemia
Lymphoma
Medulloblastoma
Melanoma
Metabolism
Neuroblastoma
Pancreatic Cancer
Prostate Cancer
Targeted Therapy
Translation
Translocations
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.